Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) requiring protected amine functionalities. Its structure allows for selective reactions at the amino group while the tert-butyl carbamate (Boc) group remains stable under various conditions, enabling stepwise construction of complex molecules. Commonly employed in the synthesis of kinase inhibitors and other bioactive compounds where a cyclohexyl linker with dual amine functions is needed. The compound’s stability and solubility profile make it suitable for solid-phase and solution-phase peptide-like synthesis. It is also utilized in medicinal chemistry for scaffold modification to improve metabolic stability and binding affinity in drug candidates.